Dyslipidemia and risk of prostate canсer in patients with urologic diseases

Aim. To assess the impact of homeostasis parameters on risk of prostate cancer.Materials and Methods. The study included 108  patients with urologic diseases and with (n = 54) or without (n = 54) prostate cancer. Median age in both groups was 67 (interquartile range 64-73) years. Clinicopathological...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Smirnov, O. V. Gruzdeva, E. V. Pomeshkin, A. I. Bragin-Maltsev
Format: Article
Language:Russian
Published: Kemerovo State Medical University 2022-03-01
Series:Фундаментальная и клиническая медицина
Subjects:
Online Access:https://fcm.kemsmu.ru/jour/article/view/513
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim. To assess the impact of homeostasis parameters on risk of prostate cancer.Materials and Methods. The study included 108  patients with urologic diseases and with (n = 54) or without (n = 54) prostate cancer. Median age in both groups was 67 (interquartile range 64-73) years. Clinicopathological data and blood test results have been collected from outpatient and inpatient records. In particular, we measured serum levels of total testosterone and prostate-specific antigen.Results. Risk factors for prostate cancer include increased total cholesterol (p = 0.023), low-density lipoprotein cholesterol (p = 0.035), total triglycerides (p = 0.048), and total testosterone (p = 0.002). High levels of total testosterone directly correlated with the tumor stage (r = 0.56). The concentration of prostate-specific antigen correlated with the lipid parameters and remained a reliable diagnostic criterion (p = 0.002).Conclusion. The association of hyper/dyslipidemia with prostate cancer provides an opportunity to improve its prevention by routine lipid screening in high-risk groups.
ISSN:2500-0764
2542-0941